BioSpace News Archive

The global market for autologous matrix-induced chondrogenesis is expected to witness a high level of competition in the next few years, states a new market intelligence study by Transparency Market Research.

The global anti snoring devices and snoring surgery market depicts a fragmented competitive landscape.

RELIEF THERAPEUTICS reported that the parent company, NRx Pharmaceuticals, Inc., of its collaboration partner with respect to aviptadil, NeuroRx, Inc. has announced that it has submitted an application to the FDA seeking EUA for the use of aviptadil to treat patients with critical COVID-19 who are at immediate risk of death from respiratory failure despite treatment with approved therapy including Remdesivir and who are ineligible for enrollment into the ACTIV-3b NIH-sponsored trial.

Amryt Pharma plc reminds shareholders of the key dates concerning the cancellation of the admission of its ordinary shares of nominal value £0.06 each to trading on AIM, as originally announced on November 22, 2021.

Sosei Group Corporation and Verily, an Alphabet precision health company, announced they have entered into a strategic research collaboration.

BioRestorative Therapies, Inc., a life sciences company focused on stem cell-based therapies, announced that Lance Alstodt, its Chief Executive Officer, will present a corporate overview at the H.C. Wainwright BioConnect 2022 Conference, being held virtually from January 10-13, 2022.

Today, Akeso, Inc. (09926.HK) announces that Cadonilimab has obtained approval from the Center for Drug Evaluation.

Notable Labs, Inc., a clinical-stage platform therapeutics company, announced the appointment of Kevin Lynch, Ph.D., MBA, as Chief Business Officer.

SQZ Biotechnologies today announced that John Maraganore, Ph.D., founding CEO of Alnylam Pharmaceuticals, has joined the company as a strategic advisor.

BD (Becton, Dickinson and Company) today released its second annual cybersecurity report to update stakeholders on the state of health care cybersecurity.